Gut microbiota and myelination: Crosstalk across the lifespan and microbiota-based modulation strategies.

This review looks at how gut bacteria affect the protective coating around nerve fibers called myelin. Healthy gut bacteria appear important for proper brain development and function. When this relationship is disrupted, it may contribute to conditions like autism, Alzheimer's disease, and multiple sclerosis. The researchers suggest that treatments targeting gut bacteria - like special diets, probiotics, or fecal transplants - might help protect nerve fibers and improve these conditions.

This comprehensive review examines the relationship between gut microbiota and myelination across the lifespan. The authors present evidence that gut bacteria critically influence myelin formation, maintenance, and regeneration through metabolic signaling, immune regulation, and neuroinflammatory pathways. The review highlights synchronized development patterns between gut microbiota and myelin during key life stages, suggesting bidirectional communication essential for neurological health. Disruptions in this gut-brain axis are identified as contributing factors in dysmyelination disorders including autism spectrum disorder, Alzheimer's disease, and multiple sclerosis.

The authors discuss therapeutic potential of microbiota-targeted interventions such as fecal microbiota transplantation, dietary modifications, and probiotics for restoring myelin integrity and reducing disease pathology.

This review suggests gut microbiota interventions may offer novel therapeutic approaches for autism spectrum disorder and other neurological conditions. Clinicians should consider gut health when assessing neurodevelopmental concerns. However, more research is needed to establish specific protocols and efficacy before clinical implementation.

As a review article, findings represent synthesis of existing literature rather than new empirical data. The abstract does not specify the quality or quantity of studies reviewed, making it difficult to assess the strength of evidence for specific claims.

Myelin, a lipid-rich sheath that insulates axons, is essential for efficient neural signal transmission and the modulation of neural circuits. Its formation, maintenance, and regeneration are tightly regulated processes that shape neurodevelopment, cognition, and emotional stability. Recent evidence positions the gut microbiota as a critical modulator of myelination, orchestrating metabolic signaling, immune homeostasis, and neuroinflammatory responses. Notably, the synchronized development and remodeling of gut microbiota and myelin across key life stages suggest a dynamic and bidirectional interplay essential for sustaining neurological health.

Disruptions in this axis are increasingly recognized as contributing factors in dysmyelination-related disorders, including autism spectrum disorder, Alzheimer's disease, and multiple sclerosis. Harnessing microbiota-targeted interventions-such as fecal microbiota transplantation, dietary modulation, and probiotic therapies-holds promise for restoring myelin integrity and mitigating disease pathology. This review provides a comprehensive synthesis of the gut microbiota-myelin interface, delineating mechanistic insights and translational opportunities for microbiome-based therapeutic strategies in neuroprotection.